Company
Janssen Biotech, Inc.
20 Case(s) (Last 5 Years)
Patents Prosecuted
| Application number | Title of the patent | IPC | Filing Date | Decision Date |
|---|---|---|---|---|
| 17496057 | Method for Treating Crohn's Disease with Anti-IL12/IL23 Antibody | C07K, A61K, A61P | Oct 6, 2021 | |
| 17489744 | Manufacturing Methods To Control C-Terminal Lysine, Galactose And Sialic Acid Content In Recombinant Proteins | C07K | Sep 28, 2021 | |
| 17472186 | IMMUNE TARGETING MOLECULES AND USES THEREOF | C07K | Sep 9, 2021 | |
| 17472198 | Methods and compositions for modulating beta chain mediated immunity | C12N, C07K, A61K, A61P | Sep 9, 2021 | Apr 22, 2024 |
| 17472237 | MULTI-SPECIFIC IMMUNE TARGETING MOLECULES AND USES THEREOF | C07K, A61P | Sep 9, 2021 | |
| 17412346 | Stable Formulations Comprising A Bispecific EGFR/C-Met Antibody | A61K, C07K, A61J | Aug 25, 2021 | |
| 17405872 | Materials and methods of using engineered ligands | A61K, A61P, C07K | Aug 17, 2021 | Apr 8, 2024 |
| 17397586 | PROTOXIN-II VARIANTS AND METHODS OF USE THEREOF | C07K, A61K | Aug 8, 2021 | |
| 17397174 | MATERIALS AND METHODS FOR PRODUCING BIOENGINEERED VIRUS SPECIFIC LYMPHOCYTES | A61K, C07K | Aug 8, 2021 | |
| 17396517 | CHIMERIC ANTIGEN RECEPTORS COMPRISING BCMA-SPECIFIC FIBRONECTIN TYPE III DOMAINS AND USES THEREOF | A61P, C07K, C12N, A61K | Aug 5, 2021 | Nov 15, 2023 |
| 17391744 | MATERIALS AND METHODS FOR MULTIDIRECTIONAL BIOTRANSPORTATION IN VIROTHERAPEUTICS | C07K | Aug 1, 2021 | |
| 17388056 | Proteins comprising HLA-G antigen binding domains and their uses | C07K, A61K, A61P | Jul 28, 2021 | Nov 27, 2023 |
| 17385284 | Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody | A61K, A61P, G16H, C07K | Jul 25, 2021 | |
| 17366769 | Method For Determining Responsiveness To Prostate Cancer Treatment | G01N, C12Q, A61K, C12N | Jul 1, 2021 | |
| 17366545 | Prostate Neoantigens And Their Uses | A61K | Jul 1, 2021 | |
| 17366946 | Prostate Neoantigens And Their Uses | C12N, A61K, A61P, C07K | Jul 1, 2021 | |
| 17364396 | METHODS OF SAFE ADMINISTRATION OF AN IRF5 ANTISENSE OLIGONUCLEOTIDE | C12N | Jun 29, 2021 | Mar 23, 2023 |
| 17349328 | MATERIALS AND METHODS FOR THE MANUFACTURE OF PLURIPOTENT STEM CELLS | C12N, A61K | Jun 15, 2021 | |
| 18003185 | MOLECULAR DISEASE PROFILE AND USE THEREOF FOR MONITORING AND TREATING RHEUMATAOID ARTHRITIS | G01N, G16B | Jun 14, 2021 | |
| 17340296 | CELL-BASED ASSAY FOR DETERMINING THE IN VITRO TUMOR KILLING ACTIVITY OF CHIMERIC ANTIGEN EXPRESSING IMMUNE CELLS | G01N | Jun 6, 2021 |